
<style>
    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');
    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');
    
    .spark-nlp-display-scroll-entities {
        border: 1px solid #E7EDF0;
        border-radius: 3px;
        text-align: justify;
        
    }
    .spark-nlp-display-scroll-entities span {  
        font-size: 14px;
        line-height: 24px;
        color: #536B76;
        font-family: 'Montserrat', sans-serif !important;
    }
    
    .spark-nlp-display-entity-wrapper{
    
        display: inline-grid;
        text-align: center;
        border-radius: 4px;
        margin: 0 2px 5px 2px;
        padding: 1px
    }
    .spark-nlp-display-entity-name{
        font-size: 14px;
        line-height: 24px;
        font-family: 'Montserrat', sans-serif !important;
        
        background: #f1f2f3;
        border-width: medium;
        text-align: center;
        
        font-weight: 400;
        
        border-radius: 5px;
        padding: 2px 5px;
        display: block;
        margin: 3px 2px;
    
    }
    .spark-nlp-display-entity-type{
        font-size: 14px;
        line-height: 24px;
        color: #ffffff;
        font-family: 'Montserrat', sans-serif !important;
        
        text-transform: uppercase;
        
        font-weight: 500;

        display: block;
        padding: 3px 5px;
    }
    
    .spark-nlp-display-entity-resolution{
        font-size: 14px;
        line-height: 24px;
        color: #ffffff;
        font-family: 'Vistol Regular', sans-serif !important;
        
        text-transform: uppercase;
        
        font-weight: 500;

        display: block;
        padding: 3px 5px;
    }
    
    .spark-nlp-display-others{
        font-size: 14px;
        line-height: 24px;
        font-family: 'Montserrat', sans-serif !important;
        
        font-weight: 400;
    }

</style>
 <span class="spark-nlp-display-others" style="background-color: white">Open Access Case Report DOI: 10.7759/cureus.37851 </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Non-small Cell Lung Carcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> With </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> to Various Levels of Vertebra: A Case Report and Literature Review  Review began 03/27/2023  Review ended 04/16/2023  Published 04/19/2023 Â© Copyright 2023 Inban et al. This is an open access article distributed under the terms of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">the Creative Commons Attribution License CC-BY </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Pugazhendi Inban </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">   , Tamer Zahdeh   , Sai Harini Chandrasekaran   , Tarsha A. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Intsiful </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">   , Chengala Ananyaa Gowthavaram   , Abasiono K. Ebong   , Yabets Kejela   , Satyam Singh   , Aadil Khan   , </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Ayushi </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> Awale  1. Department of General Medicine, Government Medical College, Omandurar, Chennai, IND  2. Internal Medicine, Hadassah Medical Center, Jerusalem, ISR 3. College of Medicine, University of Ghana Medical Center, Accra, GHA  4. Internal Medicine, Malla Reddy Institute of Medical Sciences, Hyderabad, IND 5. College of Medicine, Richmond Gabriel University, Arnos Vale, VCT 6. Department of Surgery, Hayat Hospital Medical College, Addis Ababa, ETH  7. Internal Medicine, Ganesh Shankar Vidyarthi Memorial (GSVM) Medical College, Kanpur, IND 8. Department of Internal Medicine, Lala Lajpat Rai (LLR) Hospital, Kanpur, IND 9. Internal Medicine, Star Hospital, Lalitpur, NPL Corresponding author: Sai Harini Chandrasekaran, harinisai227@gmail.com Abstract The consequences of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> over the past century have been </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">quite deadly </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and cost millions of lives. Besides the statistics that show </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">its brutal mortality rate </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the comorbidities </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> secondary to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> have had their toll and burden on patients too. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is broadly and histologically divided into </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">small and non-small cell lung cancers </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (NSCLC), with the latter associated with a heavy smoking history. Initial presentation of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">NSCLC varies </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and many patients present with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">an advanced disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> that has spread to different parts of the body. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Metastasis to the bone </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> can lead to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">severe pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> requiring </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">extreme analgesia regimens </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. Here, we present a case of a 68-year-old male with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">advanced NSCLC </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> who initially presented with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bony pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> due to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Categories: Internal Medicine, Neurosurgery, Pulmonology Keywords: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">chemotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">pet scans </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">vertebra fracture </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">spinal paraplegia </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastatic non-small cell lung cancer Introduction Lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> remains one of the leading causes of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">morbidity </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and mortality in the United States, with non- </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">small cell lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (</span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">NSCLC </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">) accounting for most cases [1]. Smoking is still the leading risk factor, making NSCLC one of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the most preventable cancers </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> because of early findings using </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">annual low-dose computed tomography (CT </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">) </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">scans [2] </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">. Many patients have </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">advanced disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> at presentation, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> vary depending on the extent of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cancer spread </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, from </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">local symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> such as </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cough </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">hemoptysis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">distant ones </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> arising from </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Bone, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">particularly the vertebral column </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, is one of the most common places where NSCLC frequently metastasizes. Approximately 20-30% of patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">non-small cell lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (</span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">NSCLC) </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> present with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bone metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> at diagnosis, and 35-60% will develop them during </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">their disease course </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Vertebral metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is a common complication of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and it occurs in 30-40% of patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">advanced disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">NSCLC bone metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> appears as </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">osteolytic lesions </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> on </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">radiographs </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, and almost all patients complain of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">aching pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> that is worse on body movements and awakes them from sleep [3]. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Managing bony metastasis symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">NSCLC </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> involves a holistic and multimodal approach to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bone metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> which include </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">chemotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">radiotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">bisphosphonates </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">opioids </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">other avenues </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. The decision to use </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">any previous interventions </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> depends on the extent of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and severity of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bony metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> responding well to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">radiotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. Generally, patients have better outcomes which depend on gender, early diagnosis, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">adenocarcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">solitary bone metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, no </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastasis to the appendicular bone </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, no </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pathologic fracture </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [4]. Surgery might even be required in patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">extensive bony metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, especially those at high risk for </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">fractures </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> or </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">spinal cord compression </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, which usually indicates a poorer prognosis [5]. Case Presentation A 68-year-old male with a known case of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">hypertension </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> was brought to the emergency department with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">sudden onset numbness </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in the lower half of the body, followed by walking difficulty for the last six hours. He also complained of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">progressive back pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> for the last six months, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">worsening </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and relieved by </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">analgesics </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> from the local physician. He was compliant with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">his medications </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> and had an extensive history of smoking with 30 pack-year, which he quit two years back. He had a history of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">dry cough </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">minimal hemoptysis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> two weeks ago and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">non-documented weight loss </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. He denied any history of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">night sweats </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">recurrent lung infections </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. On </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">physical exam </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, he was hemodynamically stable and oriented to time, place, and person. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Tendon reflexes </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">pain sensitivity </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> were preserved, and the power was 4/5 in both lower limbs. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Chest x-ray </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> revealed </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">hyperinflated lungs </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a discrete central infiltrate </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Magnetic resonance imaging (MRI) lumbosacral spine </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> showed </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">patchy areas of altered signal intensities </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> seen in multiple dorsal and lumbar vertebral bodies  How to cite this article Inban P, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Zahdeh </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> T, Chandrasekaran S, et al. (April 19, 2023) </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Non-small Cell Lung Carcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> With </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> to Various Levels of Vertebra: A Case Report and Literature Review. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Cureus </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> 15(4): e37851. DOI 10.7759/cureus.37851 â showing </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a hyperintense signal on T2 </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a hypointense signal </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> on </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">T1WI </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">A partial T2 and T11 vertebrae collapse </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">retropulsion fragments </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">epidural soft tissue </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> causing </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">compression over the spinal cord </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> was also noticed. Additionally, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a paravertebral soft tissue at T1-2 </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">T10-11 levels </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> showed </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">enhancement </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> on </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">a postcontrast scan </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, indicating </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, as shown in Figure 1. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">A whole-body CT scan </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> was done for </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">further investigation </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> to find a possible </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">primary locus of carcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">An ill-defined soft tissue </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> was found at the left hilum involving the left lung bronchus with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the destruction of dorsal vertebrae </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, as shown in Figure 2. FIGURE 1: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">MRI </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> demonstrating </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pathological collapse fracture in short tau inversion recovery (STIR) </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> weighted (a), </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">T1-weighted (b </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">), </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">T2-weighted (c, d) images of T2 and T11 vertebrae </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">. FIGURE 2: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">CT </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> demonstrating the left hilum involving the left lung bronchus (a), with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the destruction of dorsal vertebrae </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (b). The patient was then suspected of having </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung malignancy </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and was kept under </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">supportive care </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">high observation </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">A left lung bronchoscopy-guided biopsy </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> was performed. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Biopsy specimens </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> were examined and revealed </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">tissue bits </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> showing </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">alveolar spaces </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> lined by </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">hyperplastic </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">moderately pleomorphic columnar cells </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> having round to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">oval hyperchromatic nuclei </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a scant to moderate amount of eosinophilic cytoplasm </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> at places infiltrating the subepithelial tissue. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Mixed inflammatory infiltrates </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> were seen too, which confirmed the diagnosis of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">NSCLC </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. On </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">further tumor screening </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, he was positive for </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">programmed death ligand-1 </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (</span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">PD-L1 </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">) and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">endothelial growth factor receptor </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (</span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">EGFR </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">). Consequently, the patient was managed by the combination of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">cisplatin </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (50 mg/m2), </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">epirubicin </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (60 mg/m2), </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">cyclophosphamide </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (600 mg/m2) (</span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">PEC regimen </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">), given every four weeks, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">pembrolizumab </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (</span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">a monoclonal antibody </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">) to enhance immunity to fight </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">His pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> was 2023 Inban et al. Cureus 15(4): e37851. DOI 10.7759/cureus.378512 of 4 â managed with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">combination analgesia </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Discussion Lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, by far, is considered the leading cause of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cancer death </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. It is estimated that there are about 350 deaths every day due to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung malignancy </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in the United States [6]. While smoking remains the major risk factor for </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, other factors can also increase the risk, such as </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">occupational hazards </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> like asbestos exposure, which has </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a synergistic effect </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> with cigarette smoking in raising the risk for </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Radon, secondhand smoking, certain dietary habits, consuming alcohol, air pollution, and many more also contribute to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">developing lung malignancy </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [7]. Patients present with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">various symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> like </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">hemoptysis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">shortness of breath </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, or </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">recurrent localized pneumonia </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Other symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> might also be present depending on the type of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, which is broadly divided into small-cell that can be accompanied by </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">paraneoplastic syndromes </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">NSCLC </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, which is </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">further divided into more subtypes </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">most notably squamous cell carcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> (Figure 3). Some patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">NSCLC </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> can be </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">asymptomatic </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> until later in </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> when they have </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">a well- advanced presentation </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, mainly secondary to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">metastasis to other body parts </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [8]. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Bony metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is one of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the most common complications </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">unchecked lung malignancy </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Bony pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is the hallmark chief complaint, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">radiographs </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> frequently show </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">osteolytic lesions </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. FIGURE 3: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Lung carcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">its subtypes </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Vertebral metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is a common complication of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and it occurs in 30-40% of patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">advanced disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [9]. The most common sites of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">vertebral metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> are the thoracic and lumbar spine. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">The metastatic cells </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> can invade the bone tissue and cause </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bone destruction </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">which can lead </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">spinal cord compression </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pathological fractures </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [2]. The mechanism of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bone destruction </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> involves the activation of osteoclasts, which are cells that break down bone tissue. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Several factors mediate osteoclast activation </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, including </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cytokines, growth </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">tumor-derived factors </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. The clinical presentation of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">vertebral metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> depends on the location and extent of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [10]. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">The most common symptom </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, which can be localized or diffuse and can be exacerbated by movement or pressure. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">The pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> can be severe and interfere with daily activities [11]. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Spinal cord compression </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> can cause </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">neurological deficits </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, such as </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">weakness </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">numbness </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bowel or bladder dysfunction </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Pathological fractures </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> can cause </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">deformity </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">loss of mobility </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Other symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> include </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">weight loss </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">fatigue </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cough </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> [4]. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Managing lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">vertebral metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> depends on </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">several factors </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, extent of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, the location of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">the metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, the histology of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, and the patient's overall health status [12]. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">Treatment options </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> include </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">surgery </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">radiotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">chemotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">targeted therapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">pain management </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">immunotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">Managing NSCLC </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> can be complicated but depends primarily on the stage of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, along with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">other comorbidities </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> patients might have. Stage 0 and I usually respond well to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">endobronchial procedures </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">surgery </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, respectively, considering that the patient is eligible for either one of the options [8]. Stage II and beyond require more </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">extreme measures </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> involving </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">pneumonectomy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">chemotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">radiotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> [13]. In </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bony metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is a significant issue, and many patients might require </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">opioids </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> to relieve </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">their symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">Different chemotherapeutic regimens </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> are used in </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">advanced NSCLC </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">cisplatin </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> being notoriously known to be effective in managing NSCLC side by side with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">radiotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> [14]. After establishing the diagnosis, our patient was commenced on </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">the PEC regimen </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">: a combination of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">cisplatin </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (50 mg/m2), </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">epirubicin </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (60 mg/m2), and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">cyclophosphamide </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> (600 mg/m2) which were given every four weeks along with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">pembrolizumab </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">a monoclonal antibody </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, to enhance cancer-fighting immunity. The patient responded well to </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">the treatment </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> given and continued to follow up. 2023 Inban et al. Cureus 15(4): e37851. DOI 10.7759/cureus.378513 of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">4 â Conclusions Lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> is the leading cause of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cancer mortality </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. The presentation of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> can widely vary from </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">local symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> to those that result from </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">distant spreading </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Bony pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in a patient with a heavy smoking history should always raise the suspicion of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">subtle lung malignancy </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, such as the case in our patient. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Further workup </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, including </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">tissue biopsy </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">imaging </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">, is crucial to determine the type and stage of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Managing </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bony metastasis symptoms </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in NSCLC involves </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">a holistic and multimodal approach </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, involving </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">chemotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">radiotherapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">bisphosphonates </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">opioids </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, and other avenues to improve the quality of life. Additional Information Disclosures Human subjects: Consent was obtained or waived by all participants in </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">this study </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">financial support </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white"> was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. Acknowledgements Drs. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Pugazhendi Inban and Tarsha A </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Intsiful </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> were involved in the care of the discussed patient and compiled the patientâs pertinent data. Dr. Tamer Zahdeh drafted the case presentation thoroughly. Drs. Abasiono K. Ebong and Satyam Singh predominantly extracted the relevant data and worked on the Case Discussion and Introduction. Drs. Yabets Kejela and </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Ayushi </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> Awale worked on the Abstract and Conclusion and drew a pertinent discussion table. Dr. Chengala Ananyaa Gowthavaram added references using EndNote software. The whole article was proofread by Drs. Aadil Khan and Sai Harini Chandrasekaran who made the required corrections in the complete manuscript and citations. References 1. RiihimÃ¤ki M, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Hemminki A </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, Fallah M, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Thomsen H </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Sundquist K </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Sundquist J </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, Hemminki K:  </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Metastatic sites </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> and survival in </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Lung Cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. 2014, 86:78-84. 10.1016/j.lungcan.2014.07.020 2. Kim J, Lee H, Huang BW: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">: diagnosis, treatment principles, and screening . Am Fam Physician. 2022, 105:487-94. 3. Hutchinson BD, Shroff GS, Truong MT, Ko JP: Spectrum of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung adenocarcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Semin Ultrasound CT MR </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white">. 2019, 40:255-64. 10.1053/j.sult.2018.11.009 4. Tsuzuki S, Park SH, Eber MR, Peters CM, Shiozawa Y:  </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Skeletal complications </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> patients with </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">bone metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Int J Urol. 2016, 23:825-32. 10.1111/iju.13170 5. </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">Beliveau PJ </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">, Wong JJ, Sutton DA, Simon NB, BussiÃ¨res AE, Mior SA, French SD:  The chiropractic profession: a scoping review of utilization rates, reasons for seeking care, patient profiles, and care provided. Chiropr Man Therap. 2017, 25:35. 10.1186/s12998-017-0165-8 6. Chu EC, Trager RJ, Shum JS, Lai CR:  </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Pancoast tumor </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> presenting as </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">neck pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in the chiropractic office: a case report and literature review. Am J Case Rep. 2022, 23:e937052.  10.12659/AJCR.937052 7. Downs SE: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Bronchogenic carcinoma </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> presenting as </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">neuromusculoskeletal pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> . J Manipulative Physiol Ther. 1990, 13:221-4. 8. Chu EC, Trager RJ, Lee LY, Niazi IK:  A retrospective analysis of the incidence of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">severe adverse events </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> among recipients of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">chiropractic spinal manipulative therapy </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. Sci Rep. 2023, 13:1254. 10.1038/s41598-023- 28520-4 9. Maccauro G, Spinelli </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">MS </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">, Mauro S, Perisano C, Graci C, Rosa MA:  Physiopathology of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">spine metastasis </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Int J Surg Oncol. 2011, 2011:107969. 10.1155/2011/107969 10. BÃ¶rm W, Gleixner M, Klasen J: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Spinal tumors </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> in coexisting </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">degenerative spine disease--a </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">differential diagnostic problem </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">. Eur Spine J. 2004, 13:633-8. 10.1007/s00586-004-0678-4 11. Roato I: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Bone metastases </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">: when and how </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">lung cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> interacts with bone . World J Clin Oncol. 2014, 5:149- 55. 10.5306/wjco.v5.i2.149 12. Demetrious J, Demetrious GJ: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Lung cancer metastasis to the scapula and spine </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">: a case report . </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #8b6673"><span class="spark-nlp-display-entity-name">Chiropr Osteopat </span><span class="spark-nlp-display-entity-type">TREATMENT</span></span><span class="spark-nlp-display-others" style="background-color: white">. 2008, 16:8. 10.1186/1746-1340-16-8 13. Mabry LM, Ross MD, Tonarelli JM: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">Metastatic cancer </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> mimicking </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">mechanical low back pain </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white">: a case report . J Man Manip Ther. 2014, 22:162-9. 10.1179/2042618613Y.0000000056 14. Shah LM, Salzman KL: </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #77b5fe"><span class="spark-nlp-display-entity-name">Imaging </span><span class="spark-nlp-display-entity-type">TEST</span></span><span class="spark-nlp-display-others" style="background-color: white"> of </span><span class="spark-nlp-display-entity-wrapper" style="background-color: #800080"><span class="spark-nlp-display-entity-name">spinal metastatic disease </span><span class="spark-nlp-display-entity-type">PROBLEM</span></span><span class="spark-nlp-display-others" style="background-color: white"> . Int J Surg Oncol. 2011, 2011:769753. 10.1155/2011/769753 2023 Inban et al. Cureus 15(4): e37851. DOI 10.7759/cureus.378514 of 4  </span></div>